Clinical Trials Directory

Trials / Completed

CompletedNCT00420264

ThermaChoice III Under Local Sedation in the Office Setting

Feasibility of Using Gynecare Thermachoice III in the Office Setting Without Conscious Sedation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Female Pelvic Medicine & Urogynecology Institute of Michigan · Academic / Other
Sex
Female
Age
30 Years – 60 Years
Healthy volunteers
Accepted

Summary

Investigational study to determine if an endometrial ablation for heavy uterine bleeding, can be tolerated in the office setting without the use of intravenous medication.

Detailed description

A safe and effective treatment , called endometrial ablation, has been used in a hospital setting under general anesthesia for the treatment of heavy uterine bleeding. This study will evaluate if patients would tolerate the same procedure in an office setting using local anesthetics and common pain medication. This study will include twenty patients.

Conditions

Interventions

TypeNameDescription
DEVICEUterine AblationUterine Ablation in the office setting to see if the procedure is tolerated w/o sedation

Timeline

Start date
2005-11-01
Primary completion
2008-06-01
Completion
2009-05-01
First posted
2007-01-11
Last updated
2013-08-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00420264. Inclusion in this directory is not an endorsement.